Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylbutyrate vs. Benzoate in Urea Cycle Disorders
NCT02111200Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Sep 2014
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sodium phenylbutyrate and sodium benzoate in urea cycle disorder (UCD) (3 arms), sponsored by Baylor College of Medicine. Primary endpoints: Urinary Hippuric Acid at 4 days, Urinary Phenylacetylglutamine Excretion at 4 days and 1 more. Started Sep 2014; status: completed.
02
Drugs
sodium phenylbutyratesodium benzoate
03
Conditions
urea cycle disorder (UCD)
Beyond the preview
Go deeper on NCT02111200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02111200.